יום שלישי, ה׳ אלול תשפ״וTuesday, August 18, 2026
Follow Us
The effectiveness of these drugs in patients with generalized viral diseases and COVID-19, in particular, can be relatively quickly examined and made more readily available.
By JNi.Media
According to the National Institutes of Health (NIH), nearly one in five people of Ashkenazi Jewish descent are carriers of a Jewish genetic disorder.
August 14, 2026 
